Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIVAROXABAN vs ROLAPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIVAROXABAN vs ROLAPITANT: Safety Overview

Metric RIVAROXABAN ROLAPITANT
Total FAERS Reports 131,274 873
Deaths Reported 19,233 252
Death Rate 14.7% 28.9%
Hospitalizations 70,513 155
Average Patient Age 70.0 yrs 61.4 yrs
% Female Patients 47.7% 57.5%
FDA Approval Date Apr 10, 2025 Oct 25, 2017
Manufacturer Macleods Pharmaceuticals Limited TerSera Therapeutics LLC
Route ORAL ORAL
Marketing Status Prescription Prescription